BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37500151)

  • 1. Development of an Algorithm to Predict Recurrences After Resection of Liver Metastases in Patients With Metastatic Colorectal Cancer.
    Katagiri M; Sudo T; Tounann T; Kakuma T; Shimomura S; Nagasu S; Tajiri K; Fujino S; Yuge K; Murakami H; Miwa K; Hisaka T; Fujita F; Akagi Y
    Anticancer Res; 2023 Aug; 43(8):3807-3816. PubMed ID: 37500151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of postoperative carcinoembryonic antigen levels in determining post-liver-resection adjuvant chemotherapy regimens for colorectal cancer hepatic metastasis.
    Chiang JM; Hung HY; You JF; Chiang SF; Lee CF; Chou HS; Lee WC; Chan KM
    Medicine (Baltimore); 2019 Nov; 98(44):e17696. PubMed ID: 31689796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Discordance between Carcinoembryonic Antigen Levels and RECIST in Metastatic Colorectal Cancer.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Oh ST; Kim JG; Choi MH; Lee MA
    Cancer Res Treat; 2018 Jan; 50(1):283-292. PubMed ID: 28494536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncologic outcome and prognostic factors for solitary colorectal liver metastasis after liver resection.
    Hsu YJ; Chern YJ; Wu ZE; Yu YL; Liao CK; Tsai WS; You JF; Lee CW
    J Gastrointest Surg; 2024 Mar; 28(3):267-275. PubMed ID: 38445919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous cryosurgery for the treatment of hepatic colorectal metastases.
    Xu KC; Niu LZ; He WB; Hu YZ; Zuo JS
    World J Gastroenterol; 2008 Mar; 14(9):1430-6. PubMed ID: 18322961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.
    Chun YS; Vauthey JN; Boonsirikamchai P; Maru DM; Kopetz S; Palavecino M; Curley SA; Abdalla EK; Kaur H; Charnsangavej C; Loyer EM
    JAMA; 2009 Dec; 302(21):2338-44. PubMed ID: 19952320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
    Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
    Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary colorectal liver metastasis after curative intent surgery: prognostic factors affecting outcomes and survival.
    Shin H; Kim CW; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
    ANZ J Surg; 2019 Jan; 89(1-2):61-67. PubMed ID: 30484933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen half-life is an early predictor of therapeutic effects in induction chemotherapy for liver metastases from colorectal cancer.
    Nagai Y; Beppu T; Sakamoto Y; Miyamoto Y; Hayashi H; Nitta H; Imai K; Masuda T; Okabe H; Hirashima K; Imamura Y; Baba Y; Chikamoto A; Baba H
    Anticancer Res; 2014 Oct; 34(10):5529-35. PubMed ID: 25275051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic differences between patients who have undergone surgical treatment for lung metastasis or hepatic metastasis from colorectal cancer.
    Iwasaki A; Shirakusa T; Yamashita Y; Noritomi T; Maekawa T; Hamada T
    Thorac Cardiovasc Surg; 2005 Dec; 53(6):358-64. PubMed ID: 16311973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
    Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
    BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
    Lastoria S; Piccirillo MC; Caracò C; Nasti G; Aloj L; Arrichiello C; de Lutio di Castelguidone E; Tatangelo F; Ottaiano A; Iaffaioli RV; Izzo F; Romano G; Giordano P; Signoriello S; Gallo C; Perrone F
    J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.
    Huang SC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Lin CC; Jiang JK; Chang SC
    Ann Surg Oncol; 2015 Jul; 22(7):2262-8. PubMed ID: 25586242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence after complete cryoablation of colorectal liver metastases: analysis of prognostic features.
    Yan TD; Nunn DR; Morris DL
    Am Surg; 2006 May; 72(5):382-90. PubMed ID: 16719189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic assessment of carcinoembryonic antigen in the first month after liver resection for colorectal liver metastases as a rapid-recurrence predictor.
    Takamoto T; Sugawara Y; Hashimoto T; Shimada K; Inoue K; Maruyama Y; Makuuchi M
    J Surg Oncol; 2016 Mar; 113(4):463-8. PubMed ID: 27100029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.